EMILY SOMBKE: Open Payments
NPI 1770980534 · HUNTINGTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$884 in 45 payments from 13 companies in 2025. Trend: 2023 $29 · 2024 $807 · 2025 $884
Food & beverage: $884
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $311 |
| Novartis Pharmaceuticals Corporation | 5 | $146 |
| Exact Sciences Corporation | 5 | $125 |
| PFIZER INC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Amgen Inc. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
Products named: LEQVIO, Wegovy, Cologuard Collection Kit, Ozempic, Rybelsus, PREVNAR 20, ZORYVE, FARXIGA.
Industry payments across NY — which companies pay providers there.
